All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.
The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies™ protocols and other useful information.
Uridine diphosphate glucuronosyltransferase 1A6 (UGT1A6) has the ability to control the protective effect of aspirin on colon adenoma risk. It participates in glucuronidation and hydroxylation of NSAIDs (nonsteroidal anti-inflammatory drugs) as it plays an important role in NSAID metabolism. Mutation in UGT1A6 enzyme results in impaired metabolism of aspirin.
